0      0


LV012 - New Drug Updates in Hematologic Malignancies


‐ Nov 12, 2023 9:00am

Disclosures:

Rebecca Rezac has no relevant financial relationships to disclose.


Learning Objectives:

  • Review the approved label indications of new drugs and biologics in hematology/oncology
  • Describe the mechanisms of action for recently approved drugs and biologics in hematology/oncology
  • Develop plans to monitor and manage side effects associated with administration of newly approved drugs and biologics in hematology/oncology

Speaker(s):

You must be logged in and own this session in order to post comments.